Clinical trial
Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients…
NCT00328887 · Weill Medical College of Cornell University, Other · Withdrawn
Key facts
| NCT number | NCT00328887 |
|---|---|
| Title | Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma |
| Official title | Phase I, Initial Safety/Toxicity Study on the Transfer of Adenovirus With the CD40 Ligand Gene (AdCUCD40L) to Patients With Stage III or IV Esophageal Carcinoma |
| Lead sponsor | Weill Medical College of Cornell University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Esophageal Neoplasms |
| Intervention type | Genetic |
| Interventions | CD40 Gene Transfer |
| Enrollment | 0 |
| Start date | Nov 1, 2004 |
| Primary completion | Jul 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | May 24, 2006 |
| Last update posted | May 3, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: